期刊文献+

细胞免疫表型检测在急性淋巴细胞白血病诊断中的应用价值 被引量:2

The Application Value of Cell Immunity Phenotype Detection in the Diagnosis of Acute Lymphocyte Leukemia
下载PDF
导出
摘要 目的:对26例初诊或化疗未缓解的急性淋巴细胞白血病(ALL)患者进行免疫表型检测分析。方法:采集白血病患者EDTA-K2抗凝外周血或骨髓液,用流式细胞术检测髓系、T系、B系、红系、巨系分化抗原及非特异性抗原。结果:ALL患者均表达淋巴系抗原,但有部分病例同时表达髓系抗原(CD13或CD33)。3例髓系淋系双表型杂合性白血病同时表达2个以上淋系和髓系抗原标志,1例T系、B系双克隆杂合性白血病细胞分别表达两种以上T系和B系抗原。结论:细胞免疫表型检测可弥补形态学的不足,提高分型正确性,结合细胞形态学检验能为急性淋巴细胞白血病的诊断、治疗、预后判定及基础研究提供可靠的依据。 Objective:To detect and analyze immunity phenotype of 26 acute lymphocyte leukemia (All) patients who have not been relieved after preliminary diagnosis or chem.Methods:To collect EDTA-K2 anticoagulation peripheral blood or bone marrow liquid of ALL patients and detect differentiation antigen of medullary system,T system,B line,red line,huge system and non-specificity antigen by using flow cytometry method.Results:ALL patients express systema lymphaticum antigen,but some patients express medullary system antigen CD13 or CD33 meanwhile.Three patients medullary system and systema lymphaticum who are double phenotype and heterozygosita express above two medullary system and systema lymphaticum antigen maker.One patient who has double clone heterozygosita leukemia cell that is T system and B line express above two kinds of T system and B line antigen separately.Conclusions:Cellimmunity phenotype detection could redeem the insufficient of morphology and raise the correctness of grouping and giving the reliable reason for diaguosis,treatment,prognosis assessment and foundation research of ALL combining the cell morphology inspection.
出处 《中国医药导刊》 2008年第8期1245-1246,共2页 Chinese Journal of Medicinal Guide
关键词 白血病 流式细胞术 细胞免疫表型 Leukemia,Flow cytometry,Cell immunity phenotype.
  • 相关文献

参考文献2

二级参考文献13

  • 1肖志坚,郝玉书.免疫表型分析与急性白血病诊断[J].中华血液学杂志,1997,18(1):53-54. 被引量:67
  • 2Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press, 2001. 75-106.
  • 3Byrd JC, Mrozek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia : results from Cancer and Leukemia Group B ( CAL- GB 8461). Blood, 2002, 100: 4325-4336.
  • 4Wetzler M, Dodge RK, Mrozek K, et al. Prospective karyotype analysis in adult lymphoblastic leukemia: the Cancer and Leukemia Group B experience. Blood, 1999, 93: 3983-3993.
  • 5Schoch C, Schnittger S, Klaus M, et al. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood, 2003, 102: 2395-2402.
  • 6Larson RA, Dodge RK, Burns CP, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood, 1995, 85: 2025-2037.
  • 7Yanada M, Suzuki M, Kawashima K, et al. Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience. Eur J Haematol, 2005, 74: 418-423.
  • 8Chillon MC, Garcia-Sanz R, Balanzategui A, et al. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain. Haematologica, 2001, 86: 162-166.
  • 9Gfimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood, 1998, 92 : 2322-2333.
  • 10Mancini M, Scappaticci D, Cimino G, et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL) : analysis of the GIMEMA0496 protocol. Blood, 2005, 105: 3434- 3441.

共引文献1

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部